Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency

No authors listed

Clinical Trial

No authors listed. Med Lett Drugs Ther. 1970.

. 1970 Mar 20;12(6):27-8.

No abstract available

Similar articles

Dihydrogenated alkaloids of ergot in geriatric patients: symptomatic treatment of cerebrovascular insufficiency.
Kaye C. Kaye C. Bol Asoc Med P R. 1972 Nov;64(11):301-3. Bol Asoc Med P R. 1972. PMID: 4205800 No abstract available.
An ergot preparation (Hydergine) for relief of symptoms of cerebrovascular insufficiency.
Banen DM. Banen DM. J Am Geriatr Soc. 1972 Jan;20(1):22-4. doi: 10.1111/j.1532-5415.1972.tb01196.x. J Am Geriatr Soc. 1972. PMID: 4628906 Clinical Trial. No abstract available.
An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.
Jennings WG. Jennings WG. J Am Geriatr Soc. 1972 Aug;20(8):407-12. doi: 10.1111/j.1532-5415.1972.tb01645.x. J Am Geriatr Soc. 1972. PMID: 4626496 Clinical Trial. No abstract available.
[Wallerox increases cerebral circulation and heart capacity].
Heynen U. Heynen U. Z Allgemeinmed. 1971 Dec 10;47(34):1823-5. Z Allgemeinmed. 1971. PMID: 5003212 Review. German. No abstract available.
Ginkgo biloba for cerebral insufficiency.
Kleijnen J, Knipschild P. Kleijnen J, et al. Br J Clin Pharmacol. 1992 Oct;34(4):352-8. doi: 10.1111/j.1365-2125.1992.tb05642.x. Br J Clin Pharmacol. 1992. PMID: 1457269 Free PMC article. Review.

Hydergine for dementia.
Olin J, Schneider L, Novit A, Luczak S. Olin J, et al. Cochrane Database Syst Rev. 2000;2000(2):CD000359. doi: 10.1002/14651858.CD000359. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2001;(2):CD000359. doi: 10.1002/14651858.CD000359. PMID: 10796534 Free PMC article. Updated.